E-LIB Suche - Ergebnisse für: Bachanova, Veronika

1

Identification of Pre-Treatment Clinical Risk Factors Predi..:

Geethakumari, Praveen Ramakrishnan ; Wudhikarn, Kitsada ; Jain, Michael D....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S358-S359 , 2024

Link: https://doi.org/10.1016/..

2

Plain language summary of the TRANSFORM study primary analy..:

Abramson, Jeremy S ; Solomon, Scott R ; Arnason, Jon...
Future Oncology. , 2024

Link: https://doi.org/10.2217/..

3

Results from a Phase 1 Study of ACTR707 in Combination with..:

Munoz, Javier ; Flinn, Ian W. ; Cohen, Jonathon B....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. 241.e1-241.e8 , 2024

Link: https://doi.org/10.1016/..

4

JAK inhibition enhances checkpoint blockade immunotherapy i..:

Zak, Jaroslav ; Pratumchai, Isaraphorn ; Marro, Brett S....
Science. 384 (2024) 6702 - p. , 2024

Link: https://doi.org/10.1126/..

5

Kikuchi-Fujimoto disease mimicking T-cell lymphoma after CO..:

Sumransub, Nuttavut ; Bachanova, Veronika ; Linden, Michael A
American Journal of Clinical Pathology. , 2024

Link: https://doi.org/10.1093/..

6

Building the Future of CAR-T Therapy: Empowering Clinicians..:

DeLuca, Carmine ; Massey, Jessica ; Beyer, Michael...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S154-S155 , 2024

Link: https://doi.org/10.1016/..

7

Aurora Kinase a Inhibition for Gvhd and Relapse Prevention ..:

Holtan, Shernan Grace ; Walton, Kelly ; El Jurdi, Najla...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S272 , 2024

Link: https://doi.org/10.1016/..

8

A Phase I/II Study of GDA-201, Cryopreserved Nicotinamide-E..:

Shaffer, Brian C. ; Frigault, Matthew J. ; Moustafa, Muhamad Alhaj...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S196 , 2024

Link: https://doi.org/10.1016/..

9

JAK2/mTOR Inhibition Fails to Prevent Acute Gvhd Despite Re..:

Pidala, Joseph A. ; Holtan, Shernan Grace ; Walton, Kelly...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S257 , 2024

Link: https://doi.org/10.1016/..

10

The Prevalence and Impact of Pre-Transplant Frailty and Men..:

Singh, Shivjot ; Cao, Qing ; Demorest, Connor...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S128 , 2024

Link: https://doi.org/10.1016/..

11

Defining the Optimal Post-CART Monitoring Period in Recipie..:

Wesson, William ; Riedell, Peter A. ; Porter, David L....
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S206-S207 , 2024

Link: https://doi.org/10.1016/..

12

Clinical Practice Recommendations for Hematopoietic Cell Tr..:

Iqbal, Madiha ; Kumar, Ambuj ; Dreger, Peter...
Transplantation and Cellular Therapy. , 2024

Link: https://doi.org/10.1016/..

13

Chimeric antigen receptor T‐cell therapy in secondary centr..:

Alsouqi, Aseel ; Ahmed, Gulrayz ; Wang, Juntian...
American Journal of Hematology. , 2024

Link: https://doi.org/10.1002/..

14

Impact of diagnosis to treatment interval in patients with ..:

Epperla, Narendranath ; Switchenko, Jeffrey ; Bachanova, Veronika...
Blood Advances. 7 (2023) 11 - p. 2287-2296 , 2023

Link: https://doi.org/10.1182/..

15

Patient Characteristics and Outcomes of Outpatient Tisagenl..:

Ahmed, Nausheen ; Wesson, William ; Mushtaq, Muhammad Umair...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S221-S222 , 2023

Link: https://doi.org/10.1016/..